Dan Xu

433 total citations
43 papers, 264 citations indexed

About

Dan Xu is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Dan Xu has authored 43 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 17 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Dan Xu's work include Acute Myeloid Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Dan Xu is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Dan Xu collaborates with scholars based in China, United States and Greece. Dan Xu's co-authors include Fan‐Yi Meng, Qifa Liu, Jing Sun, Zhiping Fan, Hongsheng Zhou, Guopan Yu, Yongqiang Wei, Qianli Jiang, Min Dai and Fen Huang and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Dan Xu

42 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Xu China 11 168 73 56 45 43 43 264
Alessandra Cupri Italy 11 214 1.3× 88 1.2× 37 0.7× 76 1.7× 33 0.8× 27 313
Senaka Peter United States 7 104 0.6× 77 1.1× 36 0.6× 87 1.9× 52 1.2× 17 308
D Bošković Serbia 8 160 1.0× 75 1.0× 29 0.5× 37 0.8× 19 0.4× 34 254
Mariarita Sciumé Italy 9 94 0.6× 64 0.9× 29 0.5× 58 1.3× 37 0.9× 26 214
Ambra Di Veroli Italy 13 228 1.4× 118 1.6× 72 1.3× 40 0.9× 28 0.7× 31 340
Angela Rago Italy 10 179 1.1× 136 1.9× 31 0.6× 67 1.5× 41 1.0× 29 334
Michelle Cummins United Kingdom 7 245 1.5× 118 1.6× 113 2.0× 45 1.0× 13 0.3× 15 344
Dubravka Sertić Croatia 9 61 0.4× 63 0.9× 22 0.4× 110 2.4× 29 0.7× 24 287
Gail Abrahamson United Kingdom 9 260 1.5× 63 0.9× 33 0.6× 87 1.9× 23 0.5× 13 346
Gianna Maria D’Elia Italy 13 159 0.9× 116 1.6× 57 1.0× 128 2.8× 11 0.3× 33 357

Countries citing papers authored by Dan Xu

Since Specialization
Citations

This map shows the geographic impact of Dan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Xu more than expected).

Fields of papers citing papers by Dan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Xu. The network helps show where Dan Xu may publish in the future.

Co-authorship network of co-authors of Dan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Xu. A scholar is included among the top collaborators of Dan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Xu. Dan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Dan, Bingya Liu, & Lingling Wang. (2025). MiR-365-3p inhibits lung cancer proliferation and migration via CPT1A-mediated fatty acid oxidation. Scientific Reports. 15(1). 7076–7076. 2 indexed citations
2.
3.
Yu, Guopan, et al.. (2023). The Efficacy and Safety of CLAG±Ida/Mito+Ven As Salvage Therapy of Relapsed/Refractory Acute Myeloid Leukemia. Blood. 142(Supplement 1). 5909–5909. 1 indexed citations
4.
Lu, Weixiang, Guopan Yu, Yanlin Li, et al.. (2023). Identifying prognostic biomarker related to immune infiltration in acute myeloid leukemia. Clinical and Experimental Medicine. 23(8). 4553–4562.
5.
Chen, Yongheng, Qingqing Wu, Xiangjie Chen, et al.. (2021). Selective elimination of CML stem/progenitor cells by picropodophyllin in vitro and in vivo is associated with p53 activation. Biochemical and Biophysical Research Communications. 579. 1–7. 2 indexed citations
6.
7.
Xu, Ning, et al.. (2020). [Analysis of gene mutations and clinic features in 108 patients with myeloproliferative neoplasm].. PubMed. 41(7). 576–582. 1 indexed citations
8.
Yu, Guopan, Changxin Yin, Ling Jiang, et al.. (2019). Gene mutation profile and risk stratification in AML1‑ETO‑positive acute myeloid leukemia based on next‑generation sequencing. Oncology Reports. 42(6). 2333–2344. 14 indexed citations
9.
Jiang, Xuejie, Changxin Yin, Ling Jiang, et al.. (2017). Influence of FLT3-ITD Mutation and Length on the Prognosis in Acute Myeloid Leukemia. Blood. 130. 5089–5089. 1 indexed citations
10.
Chen, Weiwei, Zhixiang Wang, Xiaodong Li, et al.. (2016). Association between the concentration of imatinib in bone marrow mononuclear cells, mutation status of ABCB1 and therapeutic response in patients with chronic myelogenous leukemia. Experimental and Therapeutic Medicine. 11(5). 2061–2065. 6 indexed citations
11.
Huang, Yuli, Guohui Fan, Jian‐Qiang Zhong, et al.. (2013). Hyperhomocysteinemia is an independent risk factor in young patients with coronary artery disease in southern China. Herz. 38(7). 779–784. 28 indexed citations
12.
Meng, Fan‐Yi, et al.. (2012). Correlation between Imatinib Trough Concentration and Efficacy in Chinese Chronic Myelocytic Leukemia Patients. Acta Haematologica. 127(4). 221–227. 23 indexed citations
13.
14.
15.
16.
Sun, Ledong, Jing Sun, Kang Zeng, et al.. (2008). Autologous peripheral hematopoietic stem-cell transplantation in a patient with refractory pemphigus. Frontiers of Medicine in China. 2(2). 191–194. 1 indexed citations
17.
Liu, Qifa, Xiaodan Luo, Dan Xu, et al.. (2008). Association Between Acute Graft Versus Host Disease and Lung Injury after Allogenic Hematopoietic Stem Cell Transplantation. Blood. 112(11). 4619–4619. 1 indexed citations
18.
Xu, Dan, et al.. (2003). [Role of vascular endothelial growth factor (VEGF) in development and progress of refractory acute myeloid leukemia].. PubMed. 22(8). 844–8. 4 indexed citations
19.
Xu, Dan, Fan‐Yi Meng, & Yan Zhang. (2002). [Expression of vascular endothelial growth factor in bone marrow cells of patients with acute myeloid leukemia].. PubMed. 22(4). 357–9. 2 indexed citations
20.
Xu, Dan, et al.. (1989). The ascending branch of the lateral circumflex femoral artery. Surgical and Radiologic Anatomy. 11(4). 263–264. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandra Cupri Breakdown of academic impact, for papers by Senaka Peter Breakdown of academic impact, for papers by D Bošković Breakdown of academic impact, for papers by Mariarita Sciumé Breakdown of academic impact, for papers by Ambra Di Veroli Breakdown of academic impact, for papers by Angela Rago Breakdown of academic impact, for papers by Michelle Cummins Breakdown of academic impact, for papers by Dubravka Sertić Breakdown of academic impact, for papers by Gail Abrahamson Breakdown of academic impact, for papers by Gianna Maria D’Elia
Rankless by CCL
2026